CERS vs ABT: Which Stock is Better?
Side-by-side comparison of Cerus Corporation and Abbott Laboratories in 2026
CERS
Cerus Corporation
—
ABT
Abbott Laboratories
$93.93
Key Metrics Comparison
| Metric | CERS | ABT | Winner |
|---|---|---|---|
| Market Cap | $294.39M | $154.15B | ABT |
| P/E Ratio | N/A | 24.79 | ABT |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze CERS
Full quant analysis
Analyze ABT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CERS or ABT a better investment?
Comparing CERS and ABT: Cerus Corporation has a market cap of $294.39M while Abbott Laboratories has $154.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CERS and ABT?
CERS (Cerus Corporation) and ABT (Abbott Laboratories) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CERS or ABT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CERS or ABT?
Both CERS and ABT show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: CERS or ABT?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: CERS or ABT?
Abbott Laboratories (ABT) is larger with a market cap of $154.15B compared to $294.39M for CERS.
Should I buy CERS or ABT in 2026?
Both CERS and ABT have investment merit. CERS trades at $N/A while ABT trades at $93.93. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CERS and ABT stock?
Key differences: Market Cap ($294.39M vs $154.15B), P/E Ratio (N/A vs 24.8x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy CERS or ABT in 2026?
The choice between CERS and ABT depends on your investment goals. ABT shows higher revenue growth (0.0%). ABT has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CERS and ABT?
CERS (Cerus Corporation) has a market cap of $294.39M, while ABT (Abbott Laboratories) has a market cap of $154.15B. ABT is the larger company by market value.